Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Cigna Group (NYSE: CI) closed the day trading at $346.70 up 1.25% from the previous closing price of $342.41. In other words, the price has increased by $1.25 from its previous closing price. On the day, 1.56 million shares were traded. CI stock price reached its highest trading level at $347.06 during the session, while it also had its lowest trading level at $343.2.
Ratios:
For a better understanding of CI, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Overweight rating and assigned the stock a target price of $393.
On February 05, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $327 to $354.
Cantor Fitzgerald Upgraded its Neutral to Overweight on February 05, 2024, whereas the target price for the stock was revised from $334 to $372.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’24 when Cordani David sold 31,209 shares for $355.17 per share. The transaction valued at 11,084,357 led to the insider holds 348,054 shares of the business.
Cordani David sold 6,338 shares of CI for $2,250,682 on Mar 22 ’24. The Chairman & CEO now owns 348,054 shares after completing the transaction at $355.11 per share. On Mar 21 ’24, another insider, Cordani David, who serves as the Chairman & CEO of the company, sold 2,293 shares for $355.02 each. As a result, the insider received 814,052 and left with 348,054 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 98488451072 and an Enterprise Value of 122075455488. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.46, and their Forward P/E ratio for the next fiscal year is 10.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 2.39. Its current Enterprise Value per Revenue stands at 0.598 whereas that against EBITDA is 13.246.
Stock Price History:
Over the past 52 weeks, CI has reached a high of $365.71, while it has fallen to a 52-week low of $240.50. The 50-Day Moving Average of the stock is -1.05%, while the 200-Day Moving Average is calculated to be 11.84%.
Shares Statistics:
Over the past 3-months, CI traded about 1.49M shares per day on average, while over the past 10 days, CI traded about 1511750 shares per day. A total of 292.50M shares are outstanding, with a floating share count of 278.91M. Insiders hold about 1.82% of the company’s shares, while institutions hold 91.30% stake in the company. Shares short for CI as of 1713139200 were 3945506 with a Short Ratio of 2.65, compared to 1710460800 on 5775975. Therefore, it implies a Short% of Shares Outstanding of 3945506 and a Short% of Float of 1.39.
Dividends & Splits
CI’s forward annual dividend rate is 5.09, up from 5.09 a year ago. Against a Trailing Annual Dividend Yield of 0.0148652205The stock’s 5-year Average Dividend Yield is 0.92.
